News stories about Global Medical REIT (NASDAQ:GMRE) have trended somewhat positive recently, Accern reports. The research group identifies positive and negative press coverage by reviewing more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Global Medical REIT earned a news impact score of 0.21 on Accern’s scale. Accern also assigned headlines about the company an impact score of 46.5820296261086 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.
Global Medical REIT (GMRE) traded up $0.09 on Friday, reaching $8.80. 67,842 shares of the company’s stock traded hands, compared to its average volume of 95,397. Global Medical REIT has a fifty-two week low of $6.73 and a fifty-two week high of $10.25.
Global Medical REIT (NASDAQ:GMRE) last posted its quarterly earnings results on Thursday, August 10th. The company reported ($0.04) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.13 by ($0.17). The business had revenue of $7.42 million during the quarter, compared to analysts’ expectations of $6.16 million. Global Medical REIT had a negative return on equity of 1.53% and a negative net margin of 8.39%.
The firm also recently declared a quarterly dividend, which was paid on Monday, October 9th. Stockholders of record on Tuesday, September 26th were paid a $0.20 dividend. This represents a $0.80 annualized dividend and a dividend yield of 9.09%. The ex-dividend date of this dividend was Monday, September 25th.
A number of research analysts have issued reports on GMRE shares. DA Davidson lowered shares of Global Medical REIT from a “buy” rating to a “neutral” rating and cut their price target for the company from $11.00 to $10.00 in a research note on Tuesday, August 22nd. Zacks Investment Research lowered shares of Global Medical REIT from a “buy” rating to a “hold” rating in a research note on Tuesday, August 15th. Cantor Fitzgerald reissued an “overweight” rating and set a $12.00 price target on shares of Global Medical REIT in a report on Friday, September 1st. FBR & Co reissued a “buy” rating and set a $10.50 price target (up from $10.00) on shares of Global Medical REIT in a report on Monday, September 18th. Finally, TheStreet raised shares of Global Medical REIT from a “d” rating to a “c-” rating in a report on Monday, July 10th. Three equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. The company currently has an average rating of “Buy” and a consensus price target of $10.63.
COPYRIGHT VIOLATION NOTICE: This report was originally reported by Community Financial News and is the property of of Community Financial News. If you are viewing this report on another publication, it was illegally stolen and republished in violation of international copyright & trademark law. The correct version of this report can be viewed at https://www.com-unik.info/2017/11/04/somewhat-favorable-media-coverage-somewhat-unlikely-to-impact-global-medical-reit-gmre-share-price.html.
Global Medical REIT Company Profile
What are top analysts saying about Global Medical REIT Inc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Global Medical REIT Inc and related companies.